Global Pharmaceutical Analysis Services 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08245755

Publication Date:

August 8, 2024

Pages:

149

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Pharmaceutical Analysis Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧harmaceutical Analysis Services Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Analysis Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Analysis Services sales for 2023 through 2029. With Pharmaceutical Analysis Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Analysis Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Analysis Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Analysis Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Analysis Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Analysis Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Analysis Services.
United States market for Pharmaceutical Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical Analysis Services players cover Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Analysis Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Raw Material Analysis
Microbiological Analysis
Drug Packaging Material Analysis
Biological Analysis and Testing
Other
Segmentation by Application:
CRO
CMO and CDMO
Finished Drugs and Environment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Raw Material Analysis
Microbiological Analysis
Drug Packaging Material Analysis
Biological Analysis and Testing
Other
Segmentation by Application:
CRO
CMO and CDMO
Finished Drugs and Environment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
DYNALABS
ADPEN Laboratories
ARL Bio Pharma
West Pharmaceutical
Microbac
Element (Analytical Lab Group)
Piramal Pharma Solutions
CTI
Weipu
PONY Medicine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical Analysis Services 麻豆原创 Size 2019-2030
2.1.2 Pharmaceutical Analysis Services 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Pharmaceutical Analysis Services by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceutical Analysis Services Segment by Type
2.2.1 Raw Material Analysis
2.2.2 Microbiological Analysis
2.2.3 Drug Packaging Material Analysis
2.2.4 Biological Analysis and Testing
2.2.5 Other
2.3 Pharmaceutical Analysis Services 麻豆原创 Size by Type
2.3.1 Pharmaceutical Analysis Services 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical Analysis Services 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Pharmaceutical Analysis Services Segment by Application
2.4.1 CRO
2.4.2 CMO and CDMO
2.4.3 Finished Drugs and Environment
2.5 Pharmaceutical Analysis Services 麻豆原创 Size by Application
2.5.1 Pharmaceutical Analysis Services 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical Analysis Services 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Pharmaceutical Analysis Services 麻豆原创 Size by Player
3.1 Pharmaceutical Analysis Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical Analysis Services Revenue by Player (2019-2024)
3.1.2 Global Pharmaceutical Analysis Services Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Pharmaceutical Analysis Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Analysis Services by Region
4.1 Pharmaceutical Analysis Services 麻豆原创 Size by Region (2019-2024)
4.2 Global Pharmaceutical Analysis Services Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceutical Analysis Services 麻豆原创 Size Growth (2019-2024)
4.4 APAC Pharmaceutical Analysis Services 麻豆原创 Size Growth (2019-2024)
4.5 Europe Pharmaceutical Analysis Services 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Pharmaceutical Analysis Services 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Pharmaceutical Analysis Services 麻豆原创 Size by Country (2019-2024)
5.2 Americas Pharmaceutical Analysis Services 麻豆原创 Size by Type (2019-2024)
5.3 Americas Pharmaceutical Analysis Services 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Analysis Services 麻豆原创 Size by Region (2019-2024)
6.2 APAC Pharmaceutical Analysis Services 麻豆原创 Size by Type (2019-2024)
6.3 APAC Pharmaceutical Analysis Services 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Analysis Services 麻豆原创 Size by Country (2019-2024)
7.2 Europe Pharmaceutical Analysis Services 麻豆原创 Size by Type (2019-2024)
7.3 Europe Pharmaceutical Analysis Services 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Analysis Services by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical Analysis Services 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical Analysis Services 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Analysis Services 麻豆原创 Forecast
10.1 Global Pharmaceutical Analysis Services Forecast by Region (2025-2030)
10.1.1 Global Pharmaceutical Analysis Services Forecast by Region (2025-2030)
10.1.2 Americas Pharmaceutical Analysis Services Forecast
10.1.3 APAC Pharmaceutical Analysis Services Forecast
10.1.4 Europe Pharmaceutical Analysis Services Forecast
10.1.5 Middle East & Africa Pharmaceutical Analysis Services Forecast
10.2 Americas Pharmaceutical Analysis Services Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Pharmaceutical Analysis Services Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical Analysis Services Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical Analysis Services Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical Analysis Services Forecast
10.3 APAC Pharmaceutical Analysis Services Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical Analysis Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical Analysis Services Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical Analysis Services Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical Analysis Services Forecast
10.3.5 India 麻豆原创 Pharmaceutical Analysis Services Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical Analysis Services Forecast
10.4 Europe Pharmaceutical Analysis Services Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Pharmaceutical Analysis Services Forecast
10.4.2 France 麻豆原创 Pharmaceutical Analysis Services Forecast
10.4.3 UK 麻豆原创 Pharmaceutical Analysis Services Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical Analysis Services Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical Analysis Services Forecast
10.5 Middle East & Africa Pharmaceutical Analysis Services Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Pharmaceutical Analysis Services Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical Analysis Services Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical Analysis Services Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical Analysis Services Forecast
10.6 Global Pharmaceutical Analysis Services Forecast by Type (2025-2030)
10.7 Global Pharmaceutical Analysis Services Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical Analysis Services Forecast
11 Key Players Analysis
11.1 Eurofins
11.1.1 Eurofins Company Information
11.1.2 Eurofins Pharmaceutical Analysis Services Product Offered
11.1.3 Eurofins Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Eurofins Main Business Overview
11.1.5 Eurofins Latest Developments
11.2 WuXi AppTec
11.2.1 WuXi AppTec Company Information
11.2.2 WuXi AppTec Pharmaceutical Analysis Services Product Offered
11.2.3 WuXi AppTec Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 WuXi AppTec Main Business Overview
11.2.5 WuXi AppTec Latest Developments
11.3 Pace Analytical Services
11.3.1 Pace Analytical Services Company Information
11.3.2 Pace Analytical Services Pharmaceutical Analysis Services Product Offered
11.3.3 Pace Analytical Services Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Pace Analytical Services Main Business Overview
11.3.5 Pace Analytical Services Latest Developments
11.4 Catalent
11.4.1 Catalent Company Information
11.4.2 Catalent Pharmaceutical Analysis Services Product Offered
11.4.3 Catalent Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Catalent Main Business Overview
11.4.5 Catalent Latest Developments
11.5 LabCorp (Covance)
11.5.1 LabCorp (Covance) Company Information
11.5.2 LabCorp (Covance) Pharmaceutical Analysis Services Product Offered
11.5.3 LabCorp (Covance) Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 LabCorp (Covance) Main Business Overview
11.5.5 LabCorp (Covance) Latest Developments
11.6 PPD
11.6.1 PPD Company Information
11.6.2 PPD Pharmaceutical Analysis Services Product Offered
11.6.3 PPD Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 PPD Main Business Overview
11.6.5 PPD Latest Developments
11.7 Element (Exova)
11.7.1 Element (Exova) Company Information
11.7.2 Element (Exova) Pharmaceutical Analysis Services Product Offered
11.7.3 Element (Exova) Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Element (Exova) Main Business Overview
11.7.5 Element (Exova) Latest Developments
11.8 ALS Pharmaceutical
11.8.1 ALS Pharmaceutical Company Information
11.8.2 ALS Pharmaceutical Pharmaceutical Analysis Services Product Offered
11.8.3 ALS Pharmaceutical Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 ALS Pharmaceutical Main Business Overview
11.8.5 ALS Pharmaceutical Latest Developments
11.9 Intertek Group
11.9.1 Intertek Group Company Information
11.9.2 Intertek Group Pharmaceutical Analysis Services Product Offered
11.9.3 Intertek Group Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Intertek Group Main Business Overview
11.9.5 Intertek Group Latest Developments
11.10 SGS
11.10.1 SGS Company Information
11.10.2 SGS Pharmaceutical Analysis Services Product Offered
11.10.3 SGS Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 SGS Main Business Overview
11.10.5 SGS Latest Developments
11.11 Boston Analytical
11.11.1 Boston Analytical Company Information
11.11.2 Boston Analytical Pharmaceutical Analysis Services Product Offered
11.11.3 Boston Analytical Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Boston Analytical Main Business Overview
11.11.5 Boston Analytical Latest Developments
11.12 DYNALABS
11.12.1 DYNALABS Company Information
11.12.2 DYNALABS Pharmaceutical Analysis Services Product Offered
11.12.3 DYNALABS Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 DYNALABS Main Business Overview
11.12.5 DYNALABS Latest Developments
11.13 ADPEN Laboratories
11.13.1 ADPEN Laboratories Company Information
11.13.2 ADPEN Laboratories Pharmaceutical Analysis Services Product Offered
11.13.3 ADPEN Laboratories Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 ADPEN Laboratories Main Business Overview
11.13.5 ADPEN Laboratories Latest Developments
11.14 ARL Bio Pharma
11.14.1 ARL Bio Pharma Company Information
11.14.2 ARL Bio Pharma Pharmaceutical Analysis Services Product Offered
11.14.3 ARL Bio Pharma Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 ARL Bio Pharma Main Business Overview
11.14.5 ARL Bio Pharma Latest Developments
11.15 West Pharmaceutical
11.15.1 West Pharmaceutical Company Information
11.15.2 West Pharmaceutical Pharmaceutical Analysis Services Product Offered
11.15.3 West Pharmaceutical Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 West Pharmaceutical Main Business Overview
11.15.5 West Pharmaceutical Latest Developments
11.16 Microbac
11.16.1 Microbac Company Information
11.16.2 Microbac Pharmaceutical Analysis Services Product Offered
11.16.3 Microbac Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Microbac Main Business Overview
11.16.5 Microbac Latest Developments
11.17 Element (Analytical Lab Group)
11.17.1 Element (Analytical Lab Group) Company Information
11.17.2 Element (Analytical Lab Group) Pharmaceutical Analysis Services Product Offered
11.17.3 Element (Analytical Lab Group) Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Element (Analytical Lab Group) Main Business Overview
11.17.5 Element (Analytical Lab Group) Latest Developments
11.18 Piramal Pharma Solutions
11.18.1 Piramal Pharma Solutions Company Information
11.18.2 Piramal Pharma Solutions Pharmaceutical Analysis Services Product Offered
11.18.3 Piramal Pharma Solutions Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Piramal Pharma Solutions Main Business Overview
11.18.5 Piramal Pharma Solutions Latest Developments
11.19 CTI
11.19.1 CTI Company Information
11.19.2 CTI Pharmaceutical Analysis Services Product Offered
11.19.3 CTI Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 CTI Main Business Overview
11.19.5 CTI Latest Developments
11.20 Weipu
11.20.1 Weipu Company Information
11.20.2 Weipu Pharmaceutical Analysis Services Product Offered
11.20.3 Weipu Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Weipu Main Business Overview
11.20.5 Weipu Latest Developments
11.21 PONY Medicine
11.21.1 PONY Medicine Company Information
11.21.2 PONY Medicine Pharmaceutical Analysis Services Product Offered
11.21.3 PONY Medicine Pharmaceutical Analysis Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 PONY Medicine Main Business Overview
11.21.5 PONY Medicine Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.